AI Revolutionizes Cardiovascular CT Imaging in China
In the fast-evolving landscape of medical imaging, a quiet but profound transformation is underway—one driven not by new hardware, but by intelligent software. Across China, researchers and clinicians are harnessing artificial intelligence (AI) to redefine how cardiovascular diseases are detected, analyzed, and predicted using computed tomography (CT). At the forefront of this movement is a growing body of work centered on AI-powered cardiovascular CT imaging, a field that promises to streamline clinical workflows, enhance diagnostic precision, and unlock deeper insights into heart disease risk.
The catalyst for this shift lies in the sheer volume and complexity of data generated by modern imaging techniques. Coronary CT angiography (CCTA), now a first-line diagnostic tool for patients with suspected coronary artery disease, produces hundreds of high-resolution images per scan. With over 4.6 million CCTA exams conducted in China in 2017 alone—and numbers rising steadily—the burden on radiologists has become immense. Manual image analysis, segmentation, and interpretation are time-consuming and prone to variability. Enter artificial intelligence: a technological force capable of processing vast datasets with speed, consistency, and ever-improving accuracy.
At the Department of Diagnostic Radiology, Jinling Hospital—affiliated with Nanjing University’s Medical School and serving as the General Hospital of Eastern Theater Command—Dr. Tang Chunxiang and Dr. Zhang Longjiang have emerged as leading voices in this domain. Their recent editorial in the International Journal of Medical Radiology outlines a vision where AI is not merely an adjunct, but an integral component of the entire cardiovascular CT imaging pipeline. From image acquisition and reconstruction to automated diagnosis and long-term risk prediction, AI is being deployed at every stage, reshaping the future of cardiac care.
One of the most immediate benefits of AI in cardiovascular CT is its ability to improve image quality while reducing radiation exposure. Traditional CT reconstruction methods, such as filtered back projection, often struggle with noise, especially in low-dose scans aimed at minimizing patient risk. However, deep learning-based reconstruction techniques are proving superior. A modular neural network developed by Shan et al., for example, demonstrated competitive performance against commercial algorithms in reconstructing low-dose CT images, achieving better noise suppression and structural fidelity at significantly faster speeds. This means patients can receive lower radiation doses without sacrificing diagnostic clarity—a critical advancement in preventive cardiology.
Beyond reconstruction, AI is revolutionizing image segmentation. Tasks that once required hours of manual labor—such as delineating coronary plaques or quantifying epicardial fat—are now being automated with remarkable precision. Deep learning models can distinguish between calcified and non-calcified plaques on CCTA with results that closely match those of expert radiologists. Similarly, algorithms trained on non-contrast CT scans can automatically quantify thoracic and pericardial adipose tissue, a known biomarker for inflammation and cardiovascular risk. These tools not only save time but also reduce inter-observer variability, ensuring more consistent diagnoses across institutions.
Perhaps even more transformative is the role of AI in diagnostic decision-making. The Coronary Artery Disease Reporting and Data System (CAD-RADS) provides a standardized framework for reporting CCTA findings, but assigning the correct category can be challenging, particularly in complex cases. AI models, however, have shown promise in rapidly classifying patients into CAD-RADS categories. In one study, a deep learning algorithm was able to differentiate between CAD-RADS 0 (no stenosis) and higher-grade stenosis in just 1.4 minutes. While distinguishing between intermediate categories (e.g., CAD-RADS 2 vs. 3) remains a challenge, ongoing refinements in model architecture and training data are steadily improving classification accuracy.
But AI’s value extends far beyond simple categorization. It is increasingly being used to predict functional significance—whether a coronary stenosis is actually causing ischemia. Traditionally, this required invasive procedures like fractional flow reserve (FFR) measurement. However, non-invasive alternatives such as CT-derived FFR (FFRCT) are now available, powered by machine learning algorithms that simulate blood flow dynamics based on anatomical data from CCTA. Research led by Zhang Xiaolei, Zhang Yuanxiu, and Tang Chunxiang—using data from a multi-center Chinese FFRCT study—revealed that machine learning models could effectively identify which lesions were likely to cause myocardial ischemia. Key predictors included FFRCT values, changes in FFR (ΔFFRCT), lipid-rich plaque volume, fibrous plaque composition, and morphological complexity of the plaque. This approach not only avoids the need for invasive testing but also enables personalized treatment planning based on both anatomy and physiology.
Another frontier in AI-driven cardiovascular imaging is radiomics—the extraction of high-dimensional data from medical images that go beyond what the human eye can perceive. Unlike traditional imaging markers, which rely on visual assessment or simple measurements, radiomic features capture subtle textures, patterns, and spatial heterogeneities within tissues. In the heart, these features have been applied to myocardial tissue, coronary plaques, and perivascular fat, revealing hidden signatures of disease.
For instance, myocardial texture analysis using radiomics has shown potential in detecting myocardial fibrosis or prior infarction, even in non-contrast, low-dose CT scans. This could allow for earlier identification of patients at risk of arrhythmias or heart failure without requiring additional imaging modalities. Similarly, radiomic analysis of coronary plaques has improved the detection of high-risk features—such as thin-cap fibroatheromas or spotty calcifications—that are prone to rupture and trigger acute events like myocardial infarction.
One particularly innovative application involves the coronary perivascular fat—the layer of adipose tissue surrounding the coronary arteries. Inflammatory signals from atherosclerotic plaques can diffuse into this fat, altering its density and texture. Radiomic models trained to detect these changes can serve as indirect markers of coronary inflammation. Work by Xu Ziliang, Wen Didi, and Zhao Hongliang demonstrated that radiomic features extracted from pericoronary fat, when combined with neural network modeling, could predict the hemodynamic severity of coronary stenosis more accurately than conventional methods. Even more strikingly, research by Shang Jin, Guo Yan, and Ma Yue showed that these same features could predict the likelihood of acute coronary syndrome (ACS)—a life-threatening condition including heart attacks—before symptoms arise. This represents a paradigm shift: from diagnosing disease after it occurs to forecasting it before it strikes.
The implications of such predictive power are profound. If clinicians can identify patients at imminent risk of ACS based on subtle imaging biomarkers, they can intervene earlier with aggressive medical therapy or revascularization. This moves cardiovascular medicine closer to true precision health—where prevention is tailored not just to risk factors like cholesterol or blood pressure, but to individual biological signatures visible in imaging data.
Despite these advances, challenges remain. Most AI models today are developed and validated within single institutions, raising concerns about generalizability across diverse populations and imaging protocols. Differences in scanner types, acquisition parameters, and patient demographics can affect model performance. To address this, there is a growing push toward multi-center collaborations and standardized data formats. Initiatives like the Chinese Cardiovascular Imaging Quality Control Expert Working Group are working to harmonize imaging practices nationwide, laying the groundwork for robust, scalable AI solutions.
Moreover, while deep learning models often achieve high accuracy, their “black box” nature raises questions about interpretability and trust. Clinicians need to understand why an AI system makes a particular recommendation, especially when it contradicts human judgment. Explainable AI (XAI) methods—such as attention maps or feature importance scoring—are being explored to make models more transparent. For example, visualizing which regions of a CCTA scan contributed most to a diagnosis can help radiologists validate the AI’s conclusions and build confidence in its use.
Regulatory and ethical considerations also loom large. As AI systems become more autonomous, questions arise about accountability, data privacy, and algorithmic bias. Ensuring equitable access to AI-enhanced diagnostics across urban and rural healthcare settings will be essential to avoid widening existing disparities. Furthermore, continuous monitoring and retraining of models will be necessary to maintain performance as new imaging technologies and clinical guidelines emerge.
Yet, despite these hurdles, momentum is building. The special issue of the International Journal of Medical Radiology dedicated to AI in cardiovascular CT reflects a maturing field—one where theoretical potential is giving way to clinical reality. Contributions from teams across China highlight a vibrant research ecosystem focused on translating AI innovations into practical tools. From automated left ventricular modeling using convolutional neural networks (Zhao Runtao et al.) to comprehensive reviews on the state of the art in cardiac radiomics (Chen Qian et al.), the breadth and depth of ongoing work suggest that China is positioning itself as a global leader in AI-driven cardiovascular imaging.
What makes this progress particularly compelling is its alignment with broader national health goals. As China faces rising rates of cardiovascular disease due to aging populations and lifestyle changes, early detection and prevention have become public health imperatives. AI-enhanced CCTA offers a scalable, cost-effective strategy to screen large populations, stratify risk, and guide interventions—all while reducing the workload on overburdened healthcare providers.
Looking ahead, the integration of AI into routine clinical practice will likely follow a phased approach. Initially, AI will serve as a decision-support tool—flagging suspicious findings, prioritizing urgent cases, and automating routine measurements. Over time, as models become more reliable and trusted, they may take on greater autonomy, perhaps even initiating preliminary reports or triggering clinical alerts. Ultimately, the goal is not to replace radiologists, but to augment their expertise, allowing them to focus on complex cases and patient-centered care.
The journey of AI in cardiovascular CT is still in its early chapters. But the trajectory is clear: from passive imaging to active intelligence, from descriptive reports to predictive analytics, and from reactive treatment to proactive prevention. As Tang Chunxiang and Zhang Longjiang aptly conclude, “Let us stand at the forefront of the AI wave in cardiovascular imaging, exploring tirelessly to advance innovation and translation for the benefit of national health.”
This is not just a story of technological progress, but of human ambition—doctors, engineers, and scientists collaborating to push the boundaries of what is possible in medicine. And as AI continues to evolve, one thing remains certain: the future of cardiovascular care will be smarter, faster, and more personalized than ever before.
Tang Chunxiang, Zhang Longjiang. Department of Diagnostic Radiology, Jinling Hospital, Nanjing University Medical School, General Hospital of Eastern Theater Command, Nanjing 210002, China. International Journal of Medical Radiology. DOI: 10.19300/j.2021.S19325